ST中珠(600568.SH)半年度預虧2000萬至3000萬元
格隆匯7月14日丨ST中珠(600568.SH)公佈,預計2022年半年度經營業績將出現虧損,實現歸屬於上市公司股東的淨利潤為-2000萬元至-3000萬元左右;歸屬於上市公司股東的扣除非經常性損益的淨利潤為-3000萬元至-4000萬元左右。
主營業務影響:1、本期房地產板塊業務受政策和週期性影響較大,收入很少,本期未為公司貢獻利潤。
2、北京忠誠腫瘤醫院項目本期處於籌備開業期,費用支出較大,預計虧損約1700萬元,比上年同期略有減虧。
3、通過加強管理,提升效率,中珠正泰、一體醫療、潛江製藥等幾個主要公司虧損比上年同期有所減少,比去年減虧約1200萬元。
非經常性損益的影響:本期非經常性損益主要為本期下屬子公司廣西玉林市桂南醫院有限公司根據《廣西壯族自治區人民政府關於促進新時代廣西北部灣經濟區高水平開放高質量發展若干政策的通知》(桂政發[2020]42號),收到企業所得税退税返還金額以及其他企業收到的零星政府補助較多,去年同期同類非經常性損益很少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.